Form 4: MannKind Corp Executive Reports Stock Transaction
SEC Form 4 Filing
Burkhard Blank, EVP and Chief Medical Officer of MannKind Corp, reports a transaction involving common stock on May 24, 2024.
Summary
- On May 24, 2024, Burkhard Blank, the EVP and Chief Medical Officer of MannKind Corp, reported a transaction involving the company's common stock.
- Blank disposed of 16,151 shares of common stock at a price of $4.78.
- Following the transaction, Blank beneficially owns 351,754 shares of MannKind Corp.
- The transaction was related to the payment of tax liability by delivering or withholding securities incident to the vesting of previously reported restricted stock units.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing reporting a stock transaction by an executive. It doesn't inherently convey positive or negative sentiment.
Industry Context
This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their trading activities in the company's stock.
Stakeholder Impact
- The transaction provides transparency to shareholders regarding insider trading activity.
Key Dates
| Date | Description |
|---|---|
| 05/24/2024 | Date of stock transaction |
| 05/29/2024 | Date of signature on the report |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.